About Us

Yann Chong Tan, PhD

Founding CEO

Extensive experience in the biotech space, successful inventor and entrepreneur who co-founded a Nasdaq-listed biotech, Atreca.

Managing Director, EVX Ventures

Euan Ashley, MD, PhD

Scientific Advisory Board Member

Leading medical geneticist and cardiologist at Stanford University.
Co-founder of Personalis and other companies.

Professor of Medicine and Genetics at Stanford University  

Brian Burke, PhD

Scientific Co-Founder

Distinguished cell biologist in the area of the nuclear envelope, including lamins and the LINC complex, through the innovative use of microscopic and biochemical technologies.

Research Director at the Agency for Science, Technology and Research, Singapore

Jianming Jiang, PhD

Scientific Co-Founder

Emerging leader in investigating the regulatory mechanisms underlying cardiovascular disease through the use of AAV vectors and other cutting-edge technologies.

Asst. Prof. in Biochemistry at the National University of Singapore

Mark Kay, MD, PhD

Scientific Co-Founder

World expert in the area of gene therapy technologies for the treatment of genetic and acquired diseases, including the discovery of novel adeno-associated virus (AAV) capsids.

Head of the Division of Human Gene Therapy; and Professor of Pediatrics and Genetics at Stanford University

Cheryl Lee

Associate Director,
Project Management

Accumulated experience in research project and funding management as administrative and operations lead for both research grantees and grant funder in the Singapore public sector.

Yin Loon Lee, PhD

Co-Founder and Senior Director, Biology

As a postdoctoral fellow with Brian Burke, investigated mechanism of disease in laminopathies, and contributed to development of Nuevocor's technology.

XQ Lin

Board Member

Seasoned Innovator, Entrepreneur,

and Investor.

Chairman EVX Ventures &
Carmine Therapeutics; CEO Esco Lifesciences

David Russell

Senior Advisor

Expert on viral gene therapy and biology, and genetic manipulation of stem cells. Founded and sold Universal Cells, a biotech company built on technologies developed in his academic lab.

Professor Emeritus of Medicine at University of Washington

Idina Shi, PhD

Associate Director, Operations and Business Development

Combined business development and corporate strategy experience through tenures as biotechnology portfolio manager and science policy official in Singapore government science agency.

Colin Stewart, PhD

Scientific Co-Founder

Pioneer in techniques underpinning mouse experimental genetics, and developer of multiple mouse models for laminopathies for elucidating mechanisms of disease.

Research Director at the Agency for Science, Technology and Research, Singapore

Hendrikje Werner, PhD

Principal Scientist

As a postdoctoral fellow with Colin Stewart, played pre-eminent roles in studies that resulted in Nuevocor’s lead program as well as its target discovery platform.

Weiyi Zhang, PhD

Board Member

Pharma veteran with a wealth of industry experience in drug discovery and innovation.